209 related articles for article (PubMed ID: 38378697)
1. Plasticity-induced repression of Irf6 underlies acquired resistance to cancer immunotherapy in pancreatic ductal adenocarcinoma.
Kim IK; Diamond MS; Yuan S; Kemp SB; Kahn BM; Li Q; Lin JH; Li J; Norgard RJ; Thomas SK; Merolle M; Katsuda T; Tobias JW; Baslan T; Politi K; Vonderheide RH; Stanger BZ
Nat Commun; 2024 Feb; 15(1):1532. PubMed ID: 38378697
[TBL] [Abstract][Full Text] [Related]
2. Plasticity-induced repression of Irf6 underlies acquired resistance to cancer immunotherapy.
Kim IK; Diamond M; Yuan S; Kemp S; Li Q; Lin J; Li J; Norgard R; Thomas S; Merolle M; Katsuda T; Tobias J; Politi K; Vonderheide R; Stanger B
Res Sq; 2023 Jun; ():. PubMed ID: 37398248
[TBL] [Abstract][Full Text] [Related]
3. Expression of SNAIL in accompanying PanIN is a key prognostic indicator in pancreatic ductal adenocarcinomas.
Fujiwara S; Saiki Y; Ishizawa K; Fukushige S; Yamanaka M; Sato M; Ishida M; Motoi F; Unno M; Horii A
Cancer Med; 2019 Apr; 8(4):1671-1678. PubMed ID: 30791220
[TBL] [Abstract][Full Text] [Related]
4. Novel regulatory role of neuropilin-1 in endothelial-to-mesenchymal transition and fibrosis in pancreatic ductal adenocarcinoma.
Matkar PN; Singh KK; Rudenko D; Kim YJ; Kuliszewski MA; Prud'homme GJ; Hedley DW; Leong-Poi H
Oncotarget; 2016 Oct; 7(43):69489-69506. PubMed ID: 27542226
[TBL] [Abstract][Full Text] [Related]
5. Snail recruits Ring1B to mediate transcriptional repression and cell migration in pancreatic cancer cells.
Chen J; Xu H; Zou X; Wang J; Zhu Y; Chen H; Shen B; Deng X; Zhou A; Chin YE; Rauscher FJ; Peng C; Hou Z
Cancer Res; 2014 Aug; 74(16):4353-63. PubMed ID: 24903147
[TBL] [Abstract][Full Text] [Related]
6. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
[TBL] [Abstract][Full Text] [Related]
7. Combined MEK and STAT3 Inhibition Uncovers Stromal Plasticity by Enriching for Cancer-Associated Fibroblasts With Mesenchymal Stem Cell-Like Features to Overcome Immunotherapy Resistance in Pancreatic Cancer.
Datta J; Dai X; Bianchi A; De Castro Silva I; Mehra S; Garrido VT; Lamichhane P; Singh SP; Zhou Z; Dosch AR; Messaggio F; Ban Y; Umland O; Hosein PJ; Nagathihalli NS; Merchant NB
Gastroenterology; 2022 Dec; 163(6):1593-1612. PubMed ID: 35948109
[TBL] [Abstract][Full Text] [Related]
8. Grainyhead-like 2 (GRHL2) regulates epithelial plasticity in pancreatic cancer progression.
Nishino H; Takano S; Yoshitomi H; Suzuki K; Kagawa S; Shimazaki R; Shimizu H; Furukawa K; Miyazaki M; Ohtsuka M
Cancer Med; 2017 Nov; 6(11):2686-2696. PubMed ID: 28960866
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia and pancreatic ductal adenocarcinoma.
Yamasaki A; Yanai K; Onishi H
Cancer Lett; 2020 Aug; 484():9-15. PubMed ID: 32380129
[TBL] [Abstract][Full Text] [Related]
10. Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer.
Zheng X; Carstens JL; Kim J; Scheible M; Kaye J; Sugimoto H; Wu CC; LeBleu VS; Kalluri R
Nature; 2015 Nov; 527(7579):525-530. PubMed ID: 26560028
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of FOXO3a induces epithelial-mesenchymal transition and promotes metastasis of pancreatic ductal adenocarcinoma by activation of the β-catenin/TCF4 pathway through SPRY2.
Li J; Yang R; Dong Y; Chen M; Wang Y; Wang G
J Exp Clin Cancer Res; 2019 Jan; 38(1):38. PubMed ID: 30691517
[TBL] [Abstract][Full Text] [Related]
12. Upregulated SMAD3 promotes epithelial-mesenchymal transition and predicts poor prognosis in pancreatic ductal adenocarcinoma.
Yamazaki K; Masugi Y; Effendi K; Tsujikawa H; Hiraoka N; Kitago M; Shinoda M; Itano O; Tanabe M; Kitagawa Y; Sakamoto M
Lab Invest; 2014 Jun; 94(6):683-91. PubMed ID: 24709776
[TBL] [Abstract][Full Text] [Related]
13. Silencing ubiquitin-conjugating enzyme 2C inhibits proliferation and epithelial-mesenchymal transition in pancreatic ductal adenocarcinoma.
Wang X; Yin L; Yang L; Zheng Y; Liu S; Yang J; Cui H; Wang H
FEBS J; 2019 Dec; 286(24):4889-4909. PubMed ID: 31715067
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic Landscape in Pancreatic Ductal Adenocarcinoma: On the Way to Overcoming Drug Resistance?
Ciernikova S; Earl J; García Bermejo ML; Stevurkova V; Carrato A; Smolkova B
Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32521716
[TBL] [Abstract][Full Text] [Related]
15. Potent EMT and CSC Phenotypes Are Induced By Oncostatin-M in Pancreatic Cancer.
Smigiel JM; Parameswaran N; Jackson MW
Mol Cancer Res; 2017 Apr; 15(4):478-488. PubMed ID: 28053127
[TBL] [Abstract][Full Text] [Related]
16. The role of epithelial-mesenchymal transition and autophagy in pancreatic ductal adenocarcinoma invasion.
Yang J; Liu Y; Liu S
Cell Death Dis; 2023 Aug; 14(8):506. PubMed ID: 37550301
[TBL] [Abstract][Full Text] [Related]
17. Deciphering epithelial-to-mesenchymal transition in pancreatic cancer.
Friend C; Parajuli P; Razzaque MS; Atfi A
Adv Cancer Res; 2023; 159():37-73. PubMed ID: 37268401
[TBL] [Abstract][Full Text] [Related]
18. CD40L-armed oncolytic herpes simplex virus suppresses pancreatic ductal adenocarcinoma by facilitating the tumor microenvironment favorable to cytotoxic T cell response in the syngeneic mouse model.
Wang R; Chen J; Wang W; Zhao Z; Wang H; Liu S; Li F; Wan Y; Yin J; Wang R; Li Y; Zhang C; Zhang H; Cao Y
J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35086948
[TBL] [Abstract][Full Text] [Related]
19. Modeling pancreatic cancer in mice for experimental therapeutics.
Mallya K; Gautam SK; Aithal A; Batra SK; Jain M
Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188554. PubMed ID: 33945847
[TBL] [Abstract][Full Text] [Related]
20. Epithelial mesenchymal transition correlates with CD24+CD44+ and CD133+ cells in pancreatic cancer.
Zhang Y; Wei J; Wang H; Xue X; An Y; Tang D; Yuan Z; Wang F; Wu J; Zhang J; Miao Y
Oncol Rep; 2012 May; 27(5):1599-605. PubMed ID: 22322379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]